Global Lupus Experts Publish First Paper to Define Disease Modification in Lupus
Angela Carroll, US Medical Affairs Scientific Director-Immuno-inflammation at GlaxoSmithKline (GSK), a global health care company, discusses the first published article to put forth a definition of disease modification in systemic lupus erythematosus (SLE), including lupus nephritis (LN). Co-authored by some of the world’s top lupus experts, the paper appears in the latest issue of “Lupus Science & Medicine” (Mar 2022) and marks an important step toward identifying treat-to-target therapies for the 5 million people worldwide suffering from SLE and LN.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Angela Carroll is the US Medical Affairs Scientific Director-Immuno-inflammation at GSK. Over her 16+ years with the company, she has become a principal contributor in US Medical Affairs across multiple rheumatology compounds. She has an extensive background in medical affairs within the systemic lupus erythematosus and lupus nephritis space. Additionally, she partners with the Global medical, R&D, and commercial strategy teams to develop and execute the business’s medical affairs strategy plan. She received her master’s degree in Life Sciences at North Carolina State University. She is the co-author on the recent paper published in Lupus Science & Medicine (found here: https://lupus.bmj.com/content/9/1/e000634)
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
